ValiRx Plc (VAL) - Medical Equipment - Deals and Alliances Profile
October 2018
36
About the Report
About the Report
Summary
ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company's products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE-BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing of specific genes by targeted histone deacetylation for chromatin condensation. ValiRx's ValiMedix division sells and distributes oncology therapeutics. The company's ValiPharma division is a therapeutics division that provides technologies for the treatment of cancer. Its's ValiFinn division offers research and development services. The company also develops clinical trials, which is used to treat hormone induced refractory prostate cancer and other conditions of hormone. ValiRx is headquartered in London, the UK.
ValiRx Plc (VAL)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
ValiRx Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ValiRx Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ValiRx Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ValiRx Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ValiRx Plc, Medical Equipment, Deal Details 10
Asset Purchase 10
ValiRx Acquires Biomarkers Business Unit From Pharmatest Services For USD 0.2 Million 10
Equity Offering 12
ValiRx Raises USD1.5 Million in Private Placement of Shares 12
ValiRx Raises USD1.33 Million in Private Placement of Shares 13
ValiRx Raises USD0.05 Million in Private Placement of Shares up on Exercise of Warrants 14
ValiRx Raises USD0.1 Million in Private Placement of Shares up on Exercise of Warrants 15
ValiRx Raises USD0.7 Million in Private Placement of Shares 16
Valirx Raises Funds in Private Placement of Shares 17
Valirx Raises USD1.4 Million in Private Placement of Shares 18
Valirx Raises USD1.58 Million in Placing of Ordinary Shares 19
Acquisition 20
ValiRx Divests Its Stake In VolitionRx For USD 0.6 Million 20
ValiRx Plc-Key Competitors 21
ValiRx Plc-Key Employees 22
ValiRx Plc-Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 23
Recent Developments 24
Financial Announcements 24
Sep 25, 2018: VALIRX: Half yearly report for the period ended 30 June 2018 24
Apr 10, 2018: ValiRx: Final Results for the Year Ended 31 December 2017 26
Sep 26, 2017: Valirx: Half Yearly Report For The Period Ended 30 June 2017 30
May 05, 2017: ValiRx: Final Results for the Year Ended 31 December 2016 32
Legal and Regulatory 35
Apr 18, 2017: ValiRx: Change of Registered Office 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Figure
List of Figures
ValiRx Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ValiRx Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ValiRx Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ValiRx Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List of Table
List of Tables
ValiRx Plc, Medical Equipment, Key Facts, 2017 2
ValiRx Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ValiRx Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ValiRx Plc, Deals By Market, 2012 to YTD 2018 8
ValiRx Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ValiRx Acquires Biomarkers Business Unit From Pharmatest Services For USD 0.2 Million 10
ValiRx Raises USD1.5 Million in Private Placement of Shares 12
ValiRx Raises USD1.33 Million in Private Placement of Shares 13
ValiRx Raises USD0.05 Million in Private Placement of Shares up on Exercise of Warrants 14
ValiRx Raises USD0.1 Million in Private Placement of Shares up on Exercise of Warrants 15
ValiRx Raises USD0.7 Million in Private Placement of Shares 16
Valirx Raises Funds in Private Placement of Shares 17
Valirx Raises USD1.4 Million in Private Placement of Shares 18
Valirx Raises USD1.58 Million in Placing of Ordinary Shares 19
ValiRx Divests Its Stake In VolitionRx For USD 0.6 Million 20
ValiRx Plc, Key Competitors 21
ValiRx Plc, Key Employees 22
ValiRx Plc, Subsidiaries 23
ValiRx Plc, Joint Venture 23
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.